The use of primary and secondary doxazosin XL (8 mg) in the treatment of benign prostate hyperplasia: Is there a new approach in the event of alpha-blocker failure?
Muhammet İhsan KARAMAN, Zülfü Sertkaya, Orhan KOCA, Mehmet Akyüz, Mustafa Güneş, Metin İshak Öztürk
(Urol Res Pract 2014; 40: 35-39) DOI: 10.5152/tud.2014.31384